Effect of Latanoprost on Optic Nerve Perfusion
NCT06629129
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
46
Enrollment
OTHER_GOV
Sponsor class
Conditions
Treatment Outcome
Interventions
DRUG:
Latanoprost (0.005%)
Sponsor
Zagazig University